Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume

Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume

US Patent 9512211 · Granted Dec 6, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered TGF-beta monomers and their use for inhibiting TGF-beta signaling2025
Activin receptor type IIB variants and uses thereof2025
Anti-G-CSF antibodies and uses thereof2025
TGF-β-receptor ectodomain fusion molecules and uses thereof2025
Antibody variants with pH-dependent antigen binding for selective targeting of s2025
Antibodies selective for cells presenting EGFR at high density2024
Activin receptor type IIB variants and uses thereof2024
Antibodies and antibody fragments against HNAV1.7 channel and their use in pain 2024
TGF-β-receptor ectodomain fusion molecules and uses thereof2024
Antibody glycoconjugates and methods of production and use2023
Serum albumin binding antibodies for tuneable half-life extension of biologics2022
Humanized anti-S100A9 antibody and uses thereof2022